Magnesium influence on morphine - Induced pharmacodependence in rats

Magnesium Research

Volumn 17, Issue 1, 2004, Pages 7-13

  Nechifor, Mihai ^a   Chelarescu, Dan ^a   Miftode, Maria ^a  

^a GRIGORE T POPA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Experimental induced pharmacodependence; Magnesium; Morphine; Withdrawal syndrome

Indexed keywords

ACETIC ACID DERIVATIVE; MAGNESIUM; MAGNESIUM ACETATE; MORPHINE; NALOXONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG DEPENDENCE; EXPERIMENTAL MODEL; EXPERIMENTAL RAT; GROOMING; MAGNESIUM BLOOD LEVEL; MALE; NONHUMAN; RAT; SPECTROPHOTOMETRY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SYMPTOM; WITHDRAWAL SYNDROME;

ANIMALIA;

ACETATES; ANALGESICS, OPIOID; ANIMALS; BODY WEIGHT; DOSE-RESPONSE RELATIONSHIP, DRUG; MAGNESIUM; MALE; MODELS, BIOLOGICAL; MORPHINE; MORPHINE DEPENDENCE; NALOXONE; RATS; RATS, WISTAR; SUBSTANCE WITHDRAWAL SYNDROME; TIME FACTORS;

EID: 1642340412     PISSN: 09531424     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Goto Y, Nakamura M, Abe S, Kato M, Fukui M. Physiological correlates of abnormal behaviors in magnesium-deficient rats. Epilepsy Res 1993 ; 15 : 81-9.
2. Levine J, Stein D, Rapoport A, Kurtzman L. High serum and cerebrospinal fluid Ca/Mg ratio in recently hospitalized acutely depressed patients. Neuropsychobiology 1999 ; 39 : 63-70.
3. George MS, Rosenstein D, Rubinow DR, Kling MA. Post RM.CSF magnesium in affective disorder: lack of correlation with clinical course of treatment. Psychiatry Res 1994 ; 51 : 139-46.
4. Johnson S. Micronutrient accumulation and depletion in schizophrenia, epilepsy, autism and Parkinson's disease? Med Hypotheses 2001 ; 56 : 641-5.
5. Caille S, Espejo EF, Reneric JP, Cador M, Koob GF, Stinus L. Total neurochemical lesion of noradrenergic neurons of the locus ceruleus does not alter either naloxone-precipitated or spontaneous opiate withdrawal nor does it influence ability of clonidine to reverse opiate withdrawal. J Pharmacol Exp Ther Aug 1999 ; 290 : 881-92.
6. Di Chiara G, North RA. Neurobiology of opiate abuse. Trends Pharmacol Sci 1992 ; 13 : 185-93.
7. Bozarth MA. Ventral segmental reward system. In "Brain reward systems and abuse" Raven Press New York, 1987 ; p. 1-17.
8. Miller-Reiter E, Presslich O, Fodor G, Frey R, Siegfried K. Magnesium as an aid in opioid detoxification and withdrawal. In "Advances in Magnesium Research". Ed. Ronald Smetana, John Libbey London, 1997 ; p. 242-6.
9. Karson A, Nickel B, Schmickaly B, Fehlinger R. Hochdosierte intravenose magnesium sulphat - Diazepam Therapie - eine wirksame kombinations behandlung des delirium tremens. Magnesium Bull 1989 ; 11 : 53-7.
10. Martignoni E, Blandini F, Costa A, Sandrini G, Verzi AP, Nappi G. Modulation of noradrenergic activity by magnesium salts in panic disorders and neuronal hyper-excitability syndrome. Med Sci Res 1994 ; 22 : 429-30.
11. Durlach J, Bac P. Mechanisms of action on the nervous system in magnesium deficiency and dementia. In: Mineral and metal neurotoxicology. Eds. M Yasui, MJ Strong, K./Ota, MA Verity. CRC Press Boca-Raton, 1997 ; 201-3.
12. 2+ of N-methyl-D-aspartate activated channels. Biophys J 1990 ; 57 : 1085-90.
13. Jones CA, Zempleni E, Davis B, Reynolds GP. Glutamate stimulates dopamine release from cortical and limbic rat brain in vitro. Eur J Pharmacol Sep 1993 ; 242 : 183-7.
14. Blay SL, Ferraz MP, Calil HM, Novo NF. Plasma electrolyte changes in chronic alcoholic patients with and without delirium tremens. Acta Psiquiatr Psicol Am Lat 1981 ; 27 : 311-4.
15. Hoes MJ. Plasma concentrations of magnesium and vitamin B-1 in alcoholism and delirium tremens. Pathogenic and prognostic implications. Acta Psychiatr Belg 1981 ; 81 : 72-84.
16. 2+ J Physiol 1998 ; 506 : 13-32.
17. Chelarescu D, Nechifor M, Filip C, Negru A, Mindreci I. Magnesium influence on morphine experimental addiction in rat, Neurochemistry winter Conference, Solden, Abstract Book, 2002 ; 11.